Skip to Content
Symphonies
Exothermic R&D Squeeze
Today’s Change
—

A symphony is an automated trading strategy — Learn more about symphonies here

About

A 3‑bucket, rules‑based strategy that rides short bursts in Bloom Energy, QuantumScape, and IonQ when they pop; otherwise it rotates into the strongest recent performers across real estate/homebuilders, Asia/tech/semis, and biotech/healthcare, sizing safer picks larger.
NutHow it works
Your money is split evenly into 3 buckets. - Bucket 1: If Bloom Energy (clean energy) jumped yesterday, buy it and add a fund that rises when energy stocks fall. Otherwise, buy the past‑year leader from real estate/homebuilders/income picks. - Bucket 2: If QuantumScape (battery tech) jumped yesterday, buy it. Otherwise, own the 2 best past‑year performers from Korea/Taiwan/semiconductor/tech/industrial funds, sized larger if steadier. - Bucket 3: If IonQ (quantum tech) jumped yesterday, buy it. Otherwise, buy the past‑year leader from biotech/genomics/healthcare.
CheckmarkValue prop
Low market sensitivity (beta ~0.41) with a 3-bucket momentum design that captures burst rallies in tech, real estate, and biotech. Provides diversification and potential alpha in regime shifts, though recent out-of-sample results are mixed.
1M
3M
6M
YTD
1Y
3Y
Max
www.composer.trade
Performance
Compared to selected benchmarks
AlphaBetaR2R
SPY
0.341.190.230.48
Performance Metrics
Cumulative ReturnAnnualized ReturnTrailing 1M ReturnTrailing 3M ReturnSharpe Ratio
SPY
66.78%24.65%-0.15%0.4%1.48
Exothermic R&D Squeeze
254.5%72.49%13.69%9.45%1.59
Initial Investment
$10,000.00
Final Value
$35,449.85
Regulatory Fees
$211.24
Total Slippage
$1,197.52
Invest in this strategy
OOS Start Date
Jan 13, 2026
Trading Setting
Threshold 0.25%
Type
Stocks
Category
Tactical momentum, thematic equities, single-stock tilts, leveraged etfs, global (us/asia), tech/semis, biotech/healthcare, real estate/homebuilders
Tickers in this symphonyThis symphony trades 26 assets in total
Ticker
Type
ALNY
Alnylam Pharmaceuticals, Inc.
Stocks
ARKG
ARK Genomic Revolution ETF
Stocks
BALI
iShares U.S. Large Cap Premium Income Active ETF
Stocks
BE
Bloom Energy Corporation
Stocks
BEAM
Beam Therapeutics Inc. Common Stock
Stocks
BSX
Boston Scientific Corp.
Stocks
CRSP
CRISPR Therapeutics AG
Stocks
ERY
Direxion Daily Energy Bear 2X Shares
Stocks
EWT
iShares MSCI Taiwan ETF
Stocks
EWY
iShares MSCI South Korea ETF
Stocks

FAQ

A Composer symphony is an automated trading strategy that executes trades based on parameters of your choice. Some symphonies are similar to holding one ETF in normal conditions and rotating to a different ETF when market conditions shift, for example a 5% drop in the S&P 500, while others use complex rules with dozens of triggers. However, complex doesn’t always mean better. A simple, well-structured symphony can be just as effective as an intricate one. Learn more about how symphonies work here.

"Exothermic R&D Squeeze" is currently performing the same as yesterday today. Performance updates in real time during market hours.

"Exothermic R&D Squeeze" is currently allocated toQS, CRSP, BEandERY. Holdings automatically adjust as market conditions change based on the strategy's rules.

Year-to-date, "Exothermic R&D Squeeze" has returned 45.65%. You can adjust the performance chart above to view returns across different time horizons.

The maximum drawdown for "Exothermic R&D Squeeze" is 10.29%. The maximum drawdown measures the largest peak-to-trough decline. It's an important metric to evaluate risk and the strategy's behavior during market stress.

To invest in "Exothermic R&D Squeeze", simply click the Invest button on this page. You'll need to open an account with Composer if you don't have one yet, then you can start investing. Composer will automatically execute the trades for you based on the strategy's rules. Composer also supports trading individual stocks, ETFs, and options.